Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Cinnamon L Hardee"'
Autor:
Denise A. Carbonaro-Sarracino, Alice F. Tarantal, C. Chang I. Lee, Michael L. Kaufman, Stephen Wandro, Xiangyang Jin, Michele Martinez, Danielle N. Clark, Krista Chun, Colin Koziol, Cinnamon L. Hardee, Xiaoyan Wang, Donald B. Kohn
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 16, Iss , Pp 78-93 (2020)
Adenosine deaminase (ADA)-deficient mice and healthy rhesus monkeys were studied to determine the impact of age at treatment, vector dosage, dosing schedule, repeat administration, biodistribution, and immunogenicity after systemic delivery of lentiv
Externí odkaz:
https://doaj.org/article/95dac2eae6624eef9a74c31c79e92b59
Autor:
Donald B. Kohn, Xiangyang Jin, Michael L. Kaufman, Alice F. Tarantal, Michele L. Martinez, Cinnamon L Hardee, Charles C. Lee, Krista M. Chun, Denise A. Carbonaro-Sarracino, Stephen Wandro, Danielle N. Clark, Colin Koziol, Xiaoyan Wang
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 16, Iss, Pp 78-93 (2020)
Adenosine deaminase (ADA)-deficient mice and healthy rhesus monkeys were studied to determine the impact of age at treatment, vector dosage, dosing schedule, repeat administration, biodistribution, and immunogenicity after systemic delivery of lentiv
Autor:
Cameron Noorbakhsh, Lynn Zechiedrich, Lirio Milenka Arevalo-Soliz, Cinnamon L Hardee, Nathan R Corman, Jonathan M. Fogg
Publikováno v:
Cell & gene therapy insights
The tragic deaths of three patients in a recent AAV-based X-linked myotubular myopathy clinical trial highlight once again the pressing need for safe and reliable gene delivery vectors. Non-viral minimized DNA vectors offer one possible way to meet t
Autor:
Denise A, Carbonaro-Sarracino, Alice F, Tarantal, C Chang I, Lee, Michael L, Kaufman, Stephen, Wandro, Xiangyang, Jin, Michele, Martinez, Danielle N, Clark, Krista, Chun, Colin, Koziol, Cinnamon L, Hardee, Xiaoyan, Wang, Donald B, Kohn
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Adenosine deaminase (ADA)-deficient mice and healthy rhesus monkeys were studied to determine the impact of age at treatment, vector dosage, dosing schedule, repeat administration, biodistribution, and immunogenicity after systemic delivery of lentiv
Publikováno v:
Genes, Vol 8, Iss 2, p 65 (2017)
Genes
Genes
Uses of viral vectors have thus far eclipsed uses of non-viral vectors for gene therapy delivery in the clinic. Viral vectors, however, have certain issues involving genome integration, the inability to be delivered repeatedly, and possible host reje
Autor:
Jennifer Wherley, Andy Tu, Irena Tremcinska, Donald B. Kohn, Satiro N. De Oliveira, Christine Ryan, David Elashoff, Cinnamon L Hardee, Laurence J.N. Cooper, Francesca Giannoni, Roger P. Hollis, Arineh Sahaghian, Tristan Grogan, Behrod Katebian
Publikováno v:
De Oliveira, Satiro N; Ryan, Christine; Giannoni, Francesca; Hardee, Cinnamon L; Tremcinska, Irena; Katebian, Behrod; et al.(2013). Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.. Human gene therapy, 24(10), 824-839. UCLA: Retrieved from: http://www.escholarship.org/uc/item/7rj3w050
Chimeric antigen receptors (CARs) against CD19 have been shown to direct T-cells to specifically target B-lineage malignant cells in animal models and clinical trials, with efficient tumor cell lysis. However, in some cases, there has been insufficie
Autor:
Dianne C. Skelton, Shundi Ge, Kit L. Shaw, Eszter Pais, Crooks Gm, Donald B. Kohn, Roger P. Hollis, Cinnamon L Hardee
Publikováno v:
Gene therapy
Gene therapy, vol 16, iss 8
Gene therapy, vol 16, iss 8
An important goal of gene therapy is to be able to deliver genes, so that they express in a pattern that recapitulates the expression of an endogenous cellular gene. Although tissue-specific promoters confer selectivity, in a vector-based system, the
Autor:
James S. Economou, Begoña Comin-Anduix, David Baltimore, Roger P. Hollis, Haiguang Yang, Antoni Ribas, David I. Dorsky, Nitya G. Chakraborty, Donald B. Kohn, Swagatam Ray, Shikhar Mehrotra, Richard C. Koya, Pin Wang, Arvind Chhabra, Cinnamon L Hardee, Raja Das, Bijay Mukherji, Lili Yang
Publikováno v:
The Journal of Immunology. 181:1063-1070
Cytolytic T cell-centric active specific and adoptive immunotherapeutic approaches might benefit from the simultaneous engagement of CD4+ T cells. Considering the difficulties in simultaneously engaging CD4+ and CD8+ T cells in tumor immunotherapy, e
Autor:
Francesca Giannoni, David Baltimore, Michael L. Kaufman, Shantha Senadheera, Cinnamon L Hardee, David W. Gjertson, Rebecca Chan, Xiaoyan Wang, Ingrid Bahner, Vivian H. Gersuk, Owen N. Witte, Jennifer Wherley, Antoni Ribas, Eric H. Gschweng, James S. Economou, Donald B. Kohn
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 21(5)
Transduction and transplantation of human hematopoietic stem/progenitor cells (HSPC) with the genes for a T-cell receptor (TCR) that recognizes a tumor-associated antigen may lead to sustained long-term production of T cells expressing the TCR and co
Autor:
Vahagn Nikolian, Kit L. Shaw, Dianne C. Skelton, Tamas Alexy, Cinnamon L Hardee, Jean Park, Shundi Ge, Shantha Senadheera, Eszter Pais, Roger P. Hollis, Donald B. Kohn
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 18(7)
Although pancreatic beta-cell transplantation may serve as a potential cure for diabetes mellitus (DM), limited donor tissue availability poses a major challenge. Thus, there is a great demand to find new sources for pancreatic beta-cells. Here, we p